Intensity Therapeutics, Inc. Common stock (INTS) is a publicly traded Healthcare sector company. As of July 15, 2026, INTS trades at $4.58 with a market cap of $13.30M and a P/E ratio of -0.57. INTS moved -6.02% today. Year to date, INTS is -52.51%; over the trailing twelve months it is -41.85%. Its 52-week range spans $3.51 to $79.41. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces INTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Intensity Therapeutics, Inc. Common stock (INTS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INTS moved -6.02% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $4.58 |
| Market Cap | $13.30M |
| P/E Ratio | -0.57 |
| EPS | $-8.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $79.41 |
| 52-Week Low | $3.51 |
| Volume | 4.81K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.61M |
| Gross Margin | 0.00% |
1 analysts cover INTS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.